What is Prosoft Clinical?
Prosoft Clinical operates as a full-service Clinical Research Organization (CRO), providing comprehensive product development and analysis services tailored for the pharmaceutical, biotech, and medical device sectors. Since its inception in 1995, the company has emphasized rapid turnaround and sustained support across all product development phases. Leveraging proprietary electronic data capture and management systems, Prosoft Clinical ensures operational efficiency. Its team comprises experienced professionals with deep CRO and sponsor expertise, adept at delivering customized clinical, statistical, and regulatory solutions for diverse product applications, including pharmaceutical ANDA, 505(b)(2), NDA, and medical device 510(k) and PMA programs.
How much funding has Prosoft Clinical raised?
Prosoft Clinical has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Prosoft Clinical
PPP
Public-Private Partnership
What's next for Prosoft Clinical?
The recent strategic investment signals a pivotal moment for Prosoft Clinical, likely enabling further enhancement of its technological infrastructure and service portfolio. As a company in a large-scale late-stage funding phase, Prosoft Clinical is poised to capitalize on this capital infusion to solidify its market leadership, potentially through strategic acquisitions, expansion into new therapeutic areas, or further development of its data management platforms. This backing is expected to fuel continued innovation and operational excellence, reinforcing its value proposition to clients navigating complex regulatory pathways.
See full Prosoft Clinical company page
